Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study.

[1]  R. Wood,et al.  EARLY INTERVENTION WITH BUDESONIDE IN MILD PERSISTENT ASTHMA: A RANDOMIZED, DOUBLE-BLIND TRIAL , 2004, Pediatrics.

[2]  William W Busse,et al.  Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial , 2003, The Lancet.

[3]  D. Fleming,et al.  Self-reported asthma prevalence and control among adults--United States, 2001. , 2003, MMWR. Morbidity and mortality weekly report.

[4]  S. Holgate,et al.  Variability and lack of predictive ability of asthma end-points in clinical trials , 2002, European Respiratory Journal.

[5]  S. Weiss,et al.  The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. , 2002, American journal of respiratory and critical care medicine.

[6]  F. Santilli,et al.  Effectiveness of Montelukast versus Budesonide on Quality of Life and Bronchial Reactivity in Subjects with Mild-Persistent Asthma , 2002, International journal of immunopathology and pharmacology.

[7]  B. Lipworth,et al.  Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma. , 2002, The Journal of allergy and clinical immunology.

[8]  D. Cockcroft,et al.  Methacholine challenge: test-shortening procedures. , 2001, Chest.

[9]  G B Diette,et al.  Quality of care and outcomes of adults with asthma treated by specialists and generalists in managed care. , 2001, Archives of internal medicine.

[10]  A Tattersfield,et al.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. , 2001, American journal of respiratory and critical care medicine.

[11]  M. Di Gioacchino,et al.  Zafirlukast versus budesonide on bronchial reactivity in subjects with mild-persistent asthma. , 2001, International journal of immunopathology and pharmacology.

[12]  H Itoh,et al.  Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. , 2000, American journal of respiratory and critical care medicine.

[13]  K. Carlsen,et al.  Low‐dose inhaled budesonide once or twice daily for 27 months in children with mild asthma , 2000, Allergy.

[14]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.

[15]  T. Hartert,et al.  Epidemiology of asthma: the year in review. , 2000, Current opinion in pulmonary medicine.

[16]  D. Kellerman,et al.  Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. , 1999, The Journal of allergy and clinical immunology.

[17]  I. Herjavecz,et al.  Efficacy of once- and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma. , 1999, Respiratory medicine.

[18]  Heather Eliassen,et al.  The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. , 1999, Controlled clinical trials.

[19]  K. McDowell.  Montelukast, A Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction , 1999 .

[20]  P. Mulder,et al.  Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids. , 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

[21]  K. Carlsen,et al.  Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. , 1998, The European respiratory journal.

[22]  R. Elashoff,et al.  Preventive pharmacologic therapy among asthmatics: five years after publication of guidelines. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  F. Dekker,et al.  Once-daily budesonide in mild asthma. , 1998, Respiratory medicine.

[24]  A. Casalini,et al.  Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. , 1997, American journal of respiratory and critical care medicine.

[25]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[26]  G. Milavetz,et al.  Meta-Analysis of Controlled Trials of Drug Therapy in Mild Chronic Asthma: The Role of Inhaled Corticosteroids , 1994, The Annals of pharmacotherapy.

[27]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[28]  C. Robertson,et al.  Pediatric asthma deaths in Victoria: The mild are at risk , 1992, Pediatric pulmonology.

[29]  G. Guyatt,et al.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.

[30]  E. Ingenito,et al.  Responsiveness, inflammation, and effects of deep breaths on obstruction in mild asthma. , 1989, Journal of applied physiology.